KRRO
Korro Bio, Inc.
-0.65 (-4.70%)13.18USD212K成交股數194M市值–本益比(近四季)81.5股價營收比-100.0%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00-100% | 0.00-100% | 1.1M | 1.5M | 2.6M | 2.3M | 0.00 | 0.00-100% | 0.00 | – | – | 112K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 13.6M | 13.0M | 13.8M | 20.1M | 19.7M | 17.0M | 16.0M | 17.1M | 13.6M | 14.0M | 13.1M | 14.7M |
| 銷售管理費用 | 6.5M | 7.5M | 6.5M | 7.3M | 7.8M | 8.3M | 7.3M | 7.0M | 7.9M | 5.1M | 5.3M | 5.4M |
| 營業利益 | −20.1M-20% | −20.4M-11% | −19.2M-17% | −27.2M+13% | −25.0M+17% | −23.0M+20% | −23.3M+27% | −24.1M+20% | −21.5M | −19.1M | −18.4M | −20.1M |
| 營業利益率 | – | – | -1,764.9% | -1,863.2% | -981.2% | -1,014.5% | – | – | – | – | – | -17,933.9% |
| 稅後淨利 | −18.9M-19% | −19.6M-7% | −18.1M-14% | −25.8M+18% | −23.4M+20% | −21.2M+15% | −21.0M+19% | −21.8M+11% | −19.6M | −18.5M | −17.6M | −19.6M |
| 淨利率 | – | – | -1,657.0% | -1,765.1% | -917.1% | -933.5% | – | – | – | – | – | -17,504.5% |
| 稀釋 EPS | -1.07-57% | -1.69-25% | -1.92-15% | -2.74+13% | -2.49+2% | -2.24-97% | -2.26-96% | -2.43-97% | -2.44 | -65.08 | -63.83 | -72.20 |
| 稀釋股數 | 17.6M | 11.6M | 9.4M | 9.4M | 9.4M | 8.9M | 9.3M | 9.0M | 8.0M | 284K | 276K | 272K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 24.9M | 61.7M | 24.2M | 33.6M | 64.1M | 55.6M | 63.2M | 91.2M | 139M | 41.7M | 39.7M | 40.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 163M | 184M | 162M | 180M | 202M | 226M | 244M | 250M | 198M | 46.3M | 79.4M | 102M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 60.2M | 64.0M | 62.5M | 65.3M | 63.3M | 65.8M | 63.9M | 51.5M | 46.6M | 9.6M | 34.0M | 48.3M |
| 股東權益 | 103M | 120M | 99.0M | 115M | 139M | 160M | 180M | 198M | 151M | −153M | −135M | −118M |
| 負債比 | 36.8% | 34.8% | 38.7% | 36.2% | 31.3% | 29.1% | 26.2% | 20.6% | 23.6% | 20.7% | 42.8% | 47.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −16.1M | – | – | −24.5M+12% | – | – | – | −21.9M | – | – | −19.7M |
| 資本支出 | – | 21K | – | – | 119K | – | – | – | 5.6M | – | – | 1.5M |
| 自由現金流 | – | −16.1M | – | – | −24.6M-11% | – | – | – | −27.5M | – | – | −21.2M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -963.6% | – | – | – | – | – | – | -18,930.4% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 6.4M | +181.5% | −117M | -1,834.5% | -12.48 | −79.1M |
| FY2024 | 2.3M | – | −83.6M | -3,680.4% | -9.37 | −78.0M |
| FY2023 | 0.00 | – | −81.2M | –% | -53.08 | −75.1M |
| FY2023 | – | – | – | –% | – | – |
| FY2023 | – | – | – | –% | – | – |
| FY2023 | – | – | – | –% | – | – |
| FY2022 | 0.00 | – | −58.0M | –% | -227.42 | −58.8M |
| FY2022 | – | – | – | –% | – | – |